semaglutide journey week by week What to Expect During the First After Your First Wellness Injections - Cascade Health

Before starting, most people describe low energy, persistent food preoccupation, and stalled progress despite effort

DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability

p = 0.41) (Fig

Implications This study adds to growing evidence that GLP-1 receptor agonists have a positive effect on mental health, and thus could be a particularly good treatment option for patients with obesity and/or T2D with comorbid psychiatric illness